Back

Geographic differences in serious bleeding event rates and clinical profiles among patients with ESKD who receive peritoneal or hemodialysis, 2009-2022

25 August 2023 (17:15 - 17:45)
Organised by: Logo
Congress Presentation Part of: Renal failure and heart disease: epidemiology and mechanisms Renal Failure and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Marc Bonaca

University of Colorado Anschutz Medical Campus, Aurora (United States of America)

5 More presentations in this session

Presentation thumbnail
Impact of kidney function, ticagrelor and genetic polymorphism on high platelet reactivity
Professor W. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
The impacts of the initiation of hemodialysis for patients with newly diagnosed end-stage renal disease and normal left ventricular systolic function
Doctor Y. Fu (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
The impact of pulmonary hypertension on early postoperative period after lung transplantation with particular emphasis on kidney function
Ms M. Wajda-Pokrontka (Zabrze, PL)
Abstract Slides Video
Presentation thumbnail
Worsening renal function in patients admitted with congestive heart failure: prevalence, risk profile, and hospital readmissions
Ms A. Alshammari (New York, US)
Abstract Slides Video
Presentation thumbnail
Prevalence of systemic inflammation in individuals with atherosclerotic cardiovascular disease: baseline characteristics from the SELECT, SOUL and FLOW phase 3 trials of semaglutide
Professor N. Marx (Aachen, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Renal failure and heart disease: epidemiology and mechanisms

The Event

Event poster

ESC Congress 2023

25 August 2023 17:15 CET
You may be interested in
thumbnail
Congress Session
Atrial fibrillation management and outcomes in high-risk atrial fibrillation populations
thumbnail
Congress Presentation
Comparing the efficacy and safety of DOACs with VKAs in patients with end-stage kidney disease on dialysis and non-valvular atrial fibrillation: a systematic review and meta-analysis
thumbnail
Congress Presentation
Apixaban vs. warfarin for venous thromboembolism in renal impairment: a meta-analysis of efficacy and safety

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources